Lupin gets EIR from USFDA for Aurangabad facility

Lupin said its Aurangabad facility is involved in the manufacturing of oral solid dosage, oral liquid and powder for oral suspension products for the US Market, WHO/Global Institution markets and Indian market.

from Moneycontrol Business News https://ift.tt/2YRb4WV